Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche

Published:2017-03-20 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Chillemi Antonella,Quarona Valeria,Antonioli Luca,Ferrari Davide,Horenstein Alberto L.,Malavasi Fabio

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Fondazione CRT

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signalling;Plattner;Philos Trans R Soc Lond B Biol Sci,2016

2. Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche;Quarona;Ann N Y Acad Sci,2015

3. Immunity, inflammation and cancer: a leading role for adenosine;Antonioli;Nat Rev Cancer,2013

4. The ADP-ribosyl cyclases – the current evolutionary state of the ARCs;Ferrero;Front Biosci (Landmark Ed),2014

5. Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization;Lee;J Biol Chem,2012

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38;Frontiers in Immunology;2024-06-25

2. Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials;Journal of Personalized Medicine;2024-03-29

3. Isatuximab-pomalidomide-dexamethasone <i>versus</i> pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis;Haematologica;2024-02-01

4. Biological, pathological, and multifaceted therapeutic functions of exosomes to target cancer;Oncology Research;2024

5. Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials;Frontiers in Oncology;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3